Ixion Biotechnology

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Dedicated to discovering and developing breakthrough cell-based therapies for metabolic disorders including primary hyperoxaluria, kidney stones, and other oxalate-related conditions, and insulin-dependent diabetes.

Contact Details: 13709 Progress Boulevard Box 13 Alachua FL 32615 United States of America Tel: 904 418 1428 Fax: 904 418 1583 Email: WWW: www.ixion-biotech.com/

Loading...

Recent Publications by Ixion Biotechnology:
Immobilization of an oxalate-degrading enzyme on silicone elastomer. Urinary biomaterials are compromised by device-related urinary tract...	14th June, 2003	Ixion Biotechnology, Inc, 13709 Progress Boulevard, P O Box 13, Alachua,	J Biomed Mater Res. 2002;63(6):822-9. DOI Direct Link
Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Ductal structures of the adult pancreas contain stem cells that...	25th March, 2000	Ixion Biotechnology, 13709 Progress Blvd., Box 13, Alachua, Florida 32615,	Nat Med. 2000 Mar;6(3):278-82. DOI Direct Link

BioNews Results for Ixion Biotechnology:
Plunkett's Biotech & Genetics Industry Almanac 2009	Mindbranch:  Aug 31 2008 12:51PM Matching: biotechnology
Frost & Sullivan Awards for U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market	Frost & Sullivan:  Aug 31 2008 5:58AM Matching: biotechnology
HIV/AIDS Therapy: Scientists at Gilead Sciences, Inc. discuss research in HIV/AIDS therapy	NewsRX:  Aug 31 2008 1:29AM Matching: biotechnology
Biotechnology News Releases via PRNewswire	KCAU-TV:  Aug 30 2008 8:40PM Matching: biotechnology
How to Play Biotech Without Getting Burned	Morningstar.com:  Aug 29 2008 11:18PM Matching: biotechnology
Promote your company here: BioNewsCast - Press Release Distribution	→View more Ixion Biotechnology news.

Ixion Biotechnology Patents:
US Patent No.	Title
7202080	Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
6703017	Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
6699469	Materials and methods for treating or preventing oxalate-related disease
6355242	Materials and methods for treating or preventing oxalate-related disease
6200562	Method for reducing absorption of dietary oxalate using enzymes and microbes
→View more Ixion Biotechnology patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 261 times since April 2007, the link to the organisation's website has been followed 49 times

Recent Search Terms used to find this page: ixion biotechnology | pharmaceutical ixion | alachua biotechnology | ixion technology - florida | Ixion Biotechnology, Inc. Florida | f | Ixion biotech hyperoxaluria | ixion biotechnology cell | t | Ixion Biotechnology | .

Search for more companies in Alachua

Search for more companies in FL

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ixion Biotechnology

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.